Cargando…
Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020
BACKGROUND: Influenza A(H1N1)pdm09, A(H3N2) and B viruses were co-circulating in Europe between September 2019 and January 2020. AIM: To provide interim 2019/20 influenza vaccine effectiveness (VE) estimates from six European studies, covering 10 countries and both primary care and hospital settings...
Autores principales: | Rose, Angela, Kissling, Esther, Emborg, Hanne-Dorthe, Larrauri, Amparo, McMenamin, Jim, Pozo, Francisco, Trebbien, Ramona, Mazagatos, Clara, Whitaker, Heather, Valenciano, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078828/ https://www.ncbi.nlm.nih.gov/pubmed/32183932 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.10.2000153 |
Ejemplares similares
-
Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
por: Kissling, Esther, et al.
Publicado: (2019) -
Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
por: Rondy, Marc, et al.
Publicado: (2018) -
Abrupt termination of the 2019/20 influenza season following preventive measures against COVID-19 in Denmark, Norway and Sweden
por: Emborg, Hanne-Dorthe, et al.
Publicado: (2021) -
Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023
por: Kissling, Esther, et al.
Publicado: (2023) -
Spotlight influenza: Influenza surveillance before and after the introduction of point-of-care testing in Denmark, season 2014/15 to 2018/19
por: Benedetti, Guido, et al.
Publicado: (2021)